Artificial Inteligence Biotech Generative AI 
TechCrunch
NOVEMBER 16, 2022
AI and proteins have been in the news lately, but largely because of the efforts of research outfits like DeepMind and Baker Lab. Their machine learning models take in easily collected RNA sequence data and predict the structure a protein will take — a step that used to take weeks and expensive special equipment.
TechCrunch
MARCH 17, 2023
Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
MAY 15, 2024
Today we worry this phenomenon is playing out with enterprise adoption of generative AI. Generative AI (genAI) arrived on the scene with use cases such as “support chatbots” or “talk to your documentation apps” that were so obviously useful that many companies are well on their way to taking them into production.
Crunchbase News
APRIL 2, 2024
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.
CIO
APRIL 17, 2024
The retail industry has no shortage of cases on display where generative AI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
Crunchbase News
JUNE 4, 2024
Not surprisingly AI led the way — as it always seems to do — with a trio of a billion-or-more rounds. xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI.
Crunchbase News
SEPTEMBER 13, 2024
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Expert insights. Personalized for you.
206 
Let's personalize your content